|
1
|
Duong LM, McCarthy BJ, McLendon RE,
Dolecek TA, Kruchko C, Douglas LL and Ajani UA: Descriptive
epidemiology of malignant and nonmalignant primary spinal cord,
spinal meninges, and cauda equina tumors, United States, 2004–2007.
Cancer. 118:4220–4227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chamberlain MC and Tredway TL: Adult
primary intradural spinal cord tumors: A review. Curr Neurol
Neurosci Rep. 11:320–328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sevick RJ and Wallace CJ: MR imaging of
neoplasms of the lumbar spine. Magn Reson Imaging Clin N Am.
7539–553. (ix)1999.PubMed/NCBI
|
|
4
|
Ando M, Tamaki T, Yoshida M, Kawakami M,
Kubota S, Nakagawa Y, Iwasaki H, Tsutsui S and Yamada H:
Intraoperative spinal cord monitoring using combined motor and
sensory evoked potentials recorded from the spinal cord during
surgery for intramedullary spinal cord tumor. Clin Neurol
Neurosurg. 133:18–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Farrokh D, Fransen P and Faverly D: MR
findings of a primary intramedullary malignant melanoma: Case
report and literature review. AJNR Am J Neuroradiol. 22:1864–1866.
2001.PubMed/NCBI
|
|
6
|
Sandu N, Pöpperl G, Toubert ME, Spiriev T,
Arasho B, Orabi M and Schaller B: Current molecular imaging of
spinal tumors in clinical practice. Mol Med. 17:308–316. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomura N, Ito Y, Matsuoka H, Saginoya T,
Numazawa SI, Mizuno Y and Watanabe K: PET findings of
intramedullary tumors of the spinal cord using [18F] FDG and [11C]
methionine. AJNR Am J Neuroradiol. 34:1278–1283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Belohlávek O, Simonová G, Kantorová I,
Novotný J Jr and Liscák R: Brain metastases after stereotactic
radiosurgery using the Leksell gamma knife: Can FDG PET help to
differentiate radionecrosis from tumour progression? Eur J Nucl Med
Mol Imaging. 30:96–100. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pauleit D, Floeth F, Hamacher K,
Riemenschneider MJ, Reifenberger G, Müller HW, Zilles K, Coenen HH
and Langen KJ: O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with
MRI improves the diagnostic assessment of cerebral gliomas. Brain.
128:678–687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kebir S, Gaertner FC, Mueller M, Nelles M,
Simon M, Schäfer N, Suplich M, Schaub C, Niessen M, Mack F, et al:
18F-fluoroethyl-L-tyrosine positron emission tomography
for the differential diagnosis of tumefactive multiple sclerosis
versus glioma: A case report. Oncol Lett. 11:2195–2198.
2016.PubMed/NCBI
|
|
11
|
Kebir S, Fimmers R, Galldiks N, Schäfer N,
Mack F, Schaub C, Stuplich M, Niessen M, T Simon M Tzaridis, et al:
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic
O-(2-[18F]fluoroethyl)-L-Tyrosine PET. Clin Cancer Res.
22:2190–2196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Galldiks N, Stoffels G, Filss CP, Piroth
MD, Sabel M, Ruge MI, Herzog H, Shah NJ, Fink GR, Coenen HH and
Langen KJ: Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for
differentiation of local recurrent brain metastasis from radiation
necrosis. J Nucl Med. 53:1367–1374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buck D, Forschler A, Lapa C, Schuster T,
Vollmar P, Korn T, Nessler S, Stadelmann C, Drzezga A, Buck AK, et
al: 18F-FDG PET detects inflammatory infiltrates in spinal cord
experimental autoimmune encephalomyelitis lesions. J Nucl Med.
53:1269–1276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galldiks N, Dunkl V, Stoffels G, Hutterer
M, Rapp M, Sabel M, Reifenberger G, Kebir S, Dorn F, Blau T, et al:
Diagnosis of pseudoprogression in patients with glioblastoma using
O-(2-[(18)F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol
Imaging. 42:685–695. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rau FC, Weber WA, Wester HJ, Herz M,
Becker I, Krüger A, Schwaiger M and Senekowitsch-Schmidtke R:
O-(2-[(18)F]Fluoroethyl)-L-tyrosine (FET): A tracer for
differentiation of tumour from inflammation in murine lymph nodes.
Eur J Nucl Med Mol Imaging. 29:1039–1046. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Floeth FW, Sabel M, Stoffels G, Pauleit D,
Hamacher K, Steiger HJ and Langen KJ: Prognostic value of
18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific
incidental brain lesions. J Nucl Med. 49:730–737. 2008. View Article : Google Scholar : PubMed/NCBI
|
